19 Feb 2020 --- DuPont Nutrition & Biosciences (DuPont) is collaborating with biopharmaceutical company MRM Health to tackle a range of metabolic diseases via innovative solutions based on the human microbiome. The collaboration will combine MRM Health’s proprietary technology platform and selected DuPont strains to develop novel therapeutics based on live bacterial strain combinations. In addition, MRM Health confirmed the successful completion of its first external investment round which raised over €14 million (US$15 million). The funding will be used to advance clinical and preclinical development programs in the field of microbiome-based therapeutics.
